Physician profile
Mark S Rosenberg
NPI 1184601510
$17,282.76
in general payments reported to CMS, 2019-2025
54 companies · $3,878 in 2025
The $3,878 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,558 · 2020: $1,659 · 2021: $2,462 · 2022: $2,227 · 2023: $2,732 · 2024: $2,767 · 2025: $3,878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,375.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,915.51 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals Lp | $1,804.70 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $1,673.05 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,646.76 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $1,457.29 | 2019-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $1,194.47 | 2019-2025 | |
| Glaxosmithkline, LLC. | $653.89 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $596.51 | 2019-2025 | Jardiance, Tradjenta |
| Esperion Therapeutics, INC. | $568.93 | 2020-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $439.49 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $398.11 | 2022-2025 | |
| Amarin Pharma, INC. | $381.57 | 2019-2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $370.45 | 2022-2025 | Caplyta |
| Exact Sciences Corporation | $326.72 | 2023-2025 | Cologuard Collection Kit |
| Paratek Pharmaceuticals, INC. | $304.64 | 2022-2025 | Nuzyra, Xhance |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $279.88 | 2019-2022 | |
| Lundbeck LLC | $250.22 | 2022-2025 | Rexulti, Vyepti |
| Astellas Pharma US INC | $244.58 | 2019-2025 | Veozah |
| Vanda Pharmaceuticals INC. | $235.54 | 2020-2025 | Fanapt, Hetlioz |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $228.07 | 2020-2025 | Xifaxan |
| Medline Industries Lp | $192.89 | 2019 | |
| Axsome Therapeutics, INC. | $190.41 | 2025 | Auvelity |
| Merck Sharp & Dohme LLC | $188.82 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Idorsia Pharmaceuticals US INC | $176.52 | 2022-2023 | Quviviq |
| Sanofi-Aventis U.S. LLC | $156.88 | 2019-2025 | |
| Boston Scientific Corporation | $127.55 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $127.51 | 2019-2024 | Eohilia, Gattex, Trintellix |
| Teva Pharmaceuticals USA, INC. | $127.32 | 2019-2023 | Austedo |
| Biohaven Pharmaceuticals, INC. | $87.98 | 2020-2021 | |
| Daiichi Sankyo INC. | $87.32 | 2022-2025 | Injectafer |
| Corcept Therapeutics | $82.47 | 2025 | Korlym |
| Impel Pharmaceuticals INC. | $80.64 | 2023 | Trudhesa |
| Biohaven Pharmaceutical Holding Company Ltd. | $77.03 | 2022 | |
| Medtronic, INC. | $60.26 | 2025 | Inceptiv |
| Alkermes, INC. | $56.08 | 2021 | |
| Allergan, INC. | $45.26 | 2019-2022 | |
| Ucb, INC. | $45.09 | 2024 | Nayzilam |
| Phadia US INC. | $36.51 | 2019-2021 | |
| Indivior INC. | $36.08 | 2025 | Sublocade |
| Bausch Health US, LLC | $34.79 | 2019 | |
| Zyla Life Sciences, INC. | $31.51 | 2020 | |
| Phathom Pharmaceuticals, INC. | $31.31 | 2025 | Voquezna |
| Nevro Corp. | $30.48 | 2022 | |
| Horizon Therapeutics Plc | $24.71 | 2019-2021 | |
| Pulmonx Corporation | $24.62 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Orexo US, INC. | $23.53 | 2024 | Zubsolv |
| Inspire Medical Systems, INC. | $19.38 | 2024 | Inspire |
| Bioventus LLC | $18.23 | 2019 | |
| Philips North America LLC | $18.09 | 2020 | |
| Amneal Pharmaceuticals LLC | $17.02 | 2025 | Unithroid |
| Otsuka America Pharmaceutical, INC. | $14.70 | 2022 | |
| Eisai INC. | $14.56 | 2021 | |
| Fidia Pharma USA INC. | $13.75 | 2019 | |
| Alfasigma USA, INC. | $13.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.